DE69213057D1 - Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen - Google Patents

Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen

Info

Publication number
DE69213057D1
DE69213057D1 DE69213057T DE69213057T DE69213057D1 DE 69213057 D1 DE69213057 D1 DE 69213057D1 DE 69213057 T DE69213057 T DE 69213057T DE 69213057 T DE69213057 T DE 69213057T DE 69213057 D1 DE69213057 D1 DE 69213057D1
Authority
DE
Germany
Prior art keywords
stimulation
wound healing
prostaglandin compounds
keto prostaglandin
keto
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69213057T
Other languages
English (en)
Other versions
DE69213057T2 (de
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13554827&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69213057(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of DE69213057D1 publication Critical patent/DE69213057D1/de
Application granted granted Critical
Publication of DE69213057T2 publication Critical patent/DE69213057T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
DE69213057T 1991-03-14 1992-03-10 Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen Expired - Lifetime DE69213057T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7470291 1991-03-14

Publications (2)

Publication Number Publication Date
DE69213057D1 true DE69213057D1 (de) 1996-10-02
DE69213057T2 DE69213057T2 (de) 1997-01-09

Family

ID=13554827

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69213057T Expired - Lifetime DE69213057T2 (de) 1991-03-14 1992-03-10 Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen

Country Status (12)

Country Link
US (1) US5252605A (de)
EP (1) EP0503887B1 (de)
JP (1) JP2515458B2 (de)
KR (1) KR100221370B1 (de)
AT (1) ATE141794T1 (de)
AU (1) AU648877B2 (de)
CA (1) CA2062653C (de)
DE (1) DE69213057T2 (de)
DK (1) DK0503887T3 (de)
ES (1) ES2093774T3 (de)
GR (1) GR3021117T3 (de)
NZ (1) NZ241940A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2107669C (en) * 1992-02-07 2004-06-01 Makoto Okumura Preparation for treating wounds and hemorrhoides
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
DE69714698T2 (de) * 1996-06-10 2002-12-05 Sucampo Ag Endothelin-antagonisten
AU739343B2 (en) 1997-11-28 2001-10-11 Sucampo Ag Endothelin antagonist
TWI225398B (en) 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
BR0209863A (pt) * 2001-05-18 2004-06-08 Sucampo Ag Composição catártica
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
JPWO2004004738A1 (ja) * 2002-07-02 2005-11-04 わかもと製薬株式会社 角結膜上皮細胞障害治療薬又は予防薬
US20050124699A1 (en) * 2002-07-02 2005-06-09 Wakamoto Pharmaceutical Co., Ltd. Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells
CN1777429A (zh) * 2003-04-02 2006-05-24 尼克美制药控股有限公司 前列腺素组合物和其治疗血管痉挛的应用
JP5213448B2 (ja) * 2005-03-04 2013-06-19 スキャンポ・アーゲー 末梢血管疾患の処置のための方法および組成物
EP1984027B1 (de) 2006-01-24 2015-12-30 R-Tech Ueno, Ltd. Pharmazeutische zusammensetzung mit einer bizyklischen verbindung sowie verfahren zur stabilisierung der bicyclischen verbindung
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8513441B2 (en) * 2008-08-29 2013-08-20 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
CA2639240A1 (en) * 2008-08-29 2010-02-28 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
WO2010083597A1 (en) * 2009-01-22 2010-07-29 Apotex Pharmachem Inc. Methods of making lubiprostone and intermediates thereof
US8609729B2 (en) * 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
RU2633236C2 (ru) 2011-04-07 2017-10-11 Нексмед Холдингс, Инк. Способы и композиции для лечения болезни рейно
WO2018065826A1 (en) * 2016-10-06 2018-04-12 Sucampo Ag Multilayer beads for pharmaceutical use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740953A1 (de) * 1977-09-12 1979-03-22 Thera Ges Fuer Patente Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
JPS60208917A (ja) * 1984-02-29 1985-10-21 ジ・アツプジヨン・カンパニー Ａｒｄｓおよび多器官不全治療、予防におけるプロスタグランジンの使用
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
ES2038289T3 (es) * 1987-05-15 1993-07-16 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
ATE82499T1 (de) * 1987-09-18 1992-12-15 R Tech Ueno Ltd Okulare hypotensivagenzien.
ES2051862T3 (es) * 1987-10-02 1994-07-01 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para producir un medicamento que tiene un efecto catartico.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
EP0343904B1 (de) * 1988-05-23 1993-04-28 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Hypersphyxia verursachende Zusammensetzung
JP2579193B2 (ja) * 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体

Also Published As

Publication number Publication date
CA2062653A1 (en) 1992-09-15
DK0503887T3 (da) 1996-09-16
ATE141794T1 (de) 1996-09-15
KR920017655A (ko) 1992-10-21
JP2515458B2 (ja) 1996-07-10
EP0503887B1 (de) 1996-08-28
AU648877B2 (en) 1994-05-05
KR100221370B1 (ko) 1999-09-15
EP0503887A2 (de) 1992-09-16
NZ241940A (en) 1997-07-27
AU1286192A (en) 1992-09-17
JPH0570354A (ja) 1993-03-23
EP0503887A3 (en) 1993-01-13
US5252605A (en) 1993-10-12
DE69213057T2 (de) 1997-01-09
GR3021117T3 (en) 1996-12-31
ES2093774T3 (es) 1997-01-01
CA2062653C (en) 2002-08-20

Similar Documents

Publication Publication Date Title
DE69213057T2 (de) Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
ATE69376T1 (de) Haarwuchsmittel.
DE69028289D1 (de) Verwendung von 15-keto-Prostaglandin zur Verbesserung der encephalischen Funktion
DE69118978T2 (de) Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
DE69024744D1 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459T2 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ES2019634B3 (es) Terapia con clorfeniramina.
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH